LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMFA07100009
|
SFE 10:2(4Z,7Z)/2:0
|
4Z,7Z-Decadienyl acetate
|
SFE 12:2
|
C12H20O2
|
196.146330
|
LMFA07040197
|
Assimiloside A
|
16-(beta-d-xylopyranosyl-(1-6)-beta-d-xylopyranosyl-(1-2)]-beta-d-glucopyranosyl)-26R-hydroxy-hexadeca-4R-olide
|
|
C44H80O17
|
880.539555
|
LMFA07090168
|
Glc-10/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C48H87NO15
|
917.607574
|
LMFA07090169
|
Glc-6/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-hexanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C44H79NO15
|
861.544974
|
LMFA07090170
|
Glc-10/8/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-octanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C46H83NO15
|
889.576274
|
LMFA07090171
|
Glc-10/10/8/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-octanoyloxy)-decanoyl)-glycine
|
|
C46H83NO15
|
889.576274
|
LMFA07090172
|
Glc-8/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-octanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C46H83NO15
|
889.576274
|
LMFA07090173
|
Glc-10/10/10/8-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-octanoyl)-glycine
|
|
C46H83NO15
|
889.576274
|
LMFA07090174
|
Glc-10/10/10/12-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-dodecanoyl)-glycine
|
|
C50H91NO15
|
945.638874
|
LMFA07090175
|
Glc-12/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-dodecanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C50H91NO15
|
945.638874
|
LMFA07070114
|
O-7Z-tetradecenoyl-R-Carnitine
|
3-[(7Z)-tetradecenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:1
|
C21H39NO4
|
369.287909
|
LMFA07070115
|
O-5Z-dodecenoyl-R-Carnitine
|
3-[(5Z)-dodecenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:1
|
C19H35NO4
|
341.256609
|
LMFA07070116
|
O-3Z-decenoyl-R-Carnitine
|
3-[(3Z)-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
LMFA07070117
|
O-3Z,6Z,9Z,12Z-octadecatetraenoyl-R-Carnitine
|
3-[(3Z,6Z,9Z,12Z)-octadecatetraenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:4
|
C25H41NO4
|
419.303559
|
LMFA07070118
|
O-4Z,7Z,10Z-hexadecatrienoyl-R-Carnitine
|
3-[(4Z,7Z,10Z)-hexadecatrienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:3
|
C23H39NO4
|
393.287909
|
LMFA07050492
|
Elaidoyl-CoA
|
9E-octadecanoyl-CoA
|
CoA 18:1
|
C39H68N7O17P3S
|
1031.360534
|
LMFA07050493
|
5E-tetradecenoyl-CoA
|
5E-tetradecenoyl-CoA
|
CoA 14:1
|
C35H60N7O17P3S
|
975.297934
|
LMFA07070119
|
5E-tetradecenoylcarnitine
|
O-5E-tetradecenoyl-R-Carnitine
|
CAR 14:1
|
C21H39NO4
|
369.287909
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4
|
423.334859
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
LMFA07070127
|
2E,7Z-Hexadecadienoylcarnitine
|
3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
LMFA07070128
|
(7Z)-3S-hydroxyhexadecenoylcarnitine
|
3S-{[(7Z)-3-hydroxyhexadec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:1;O
|
C23H43NO5
|
413.314124
|
LMFA07070129
|
(5Z)-3S-hydroxytetradecenoylcarnitine
|
3S-{[(5Z)-3-hydroxytetradec-5-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
LMFA07070130
|
2E,5Z-tetradecadienoylcarnitine
|
3-[(2E,5Z)-tetradeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
LMFA07070134
|
2E,decenoylcarnitine
|
3-[(2E-decenoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 10:1
|
C17H31NO4
|
313.225309
|
LMFA07070133
|
3S-hydroxyoctanoylcarnitine
|
3S-{[-3-hydroxyoctanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 8:0;O
|
C15H29NO5
|
303.204574
|
LMFA07070132
|
3S-hydroxydecanoylcarnitine
|
3S-{[-3-hydroxydecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 10:0;O
|
C17H33NO5
|
331.235874
|
LMFA07070131
|
3S-hydroxyhexadecanoylcarnitine
|
3S-{[-3-hydroxyhexadecanoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 16:0;O
|
C23H45NO5
|
415.329774
|
LMFA07050494
|
15-oxo-ETE-CoA
|
15-oxo-5Z,8Z,11Z,13E-eicosatetraenoyl-CoA
|
CoA 20:5;O
|
C41H64N7O18P3S
|
1067.324149
|
LMFA07100010
|
15Z-Insignoic acid D
|
Ethyl 4-oxotetracosa-2E,5E,15Z-trienoate
|
SFE 26:4;O
|
C26H44O3
|
404.329045
|
LMFA07100011
|
16Z-Insignoic acid D
|
Ethyl 4-oxotetracosa-2E,5E,16Z-trienoate
|
SFE 26:4;O
|
C26H44O3
|
404.329045
|
LMFA07100012
|
17Z-Insignoic acid D
|
Ethyl 4-oxotetracosa-2E,5E,17Z-trienoate
|
FA 26:4;O
|
C26H44O3
|
404.329045
|
LMFA07100013
|
18Z-Insignoic acid D
|
Ethyl 4-oxotetracosa-2E,5E,18Z-trienoate
|
FA 26:4;O
|
C26H44O3
|
404.329045
|
LMFA07100014
|
15Z-Insignoic acid E
|
Ethyl 6-ethoxy-4-oxotetracosa-2E,15Z-dienoate
|
SFE 28:3;O2
|
C28H50O4
|
450.370910
|
LMFA07100015
|
16Z-Insignoic acid E
|
Ethyl 6-ethoxy-4-oxotetracosa-2E,16Z-dienoate
|
SFE 28:3;O2
|
C28H50O4
|
450.370910
|
LMFA07100016
|
17Z-Insignoic acid E
|
Ethyl 6-ethoxy-4-oxotetracosa-2E,17Z-dienoate
|
SFE 28:3;O2
|
C28H50O4
|
450.370910
|
LMFA07090176
|
Bourgeanic acid
|
3S-hydroxy-2S,4R,6R-trimethyloctanoyloxy 3S-hydroxy-2S,4R,6R-trimethyloctanoic acid
|
FAHFA 22:1;O2
|
C22H42O5
|
386.303225
|
LMFA07040201
|
Passifetilactone E
|
5S-hydroxy-2Z-icosen-4R-olide
|
FA 19:2;O
|
C20H36O3
|
324.266445
|
LMFA07040200
|
Passifetilactone C
|
2Z-icosen-5S-olide
|
FA 20:2
|
C20H36O2
|
308.271530
|
LMFA07040199
|
Passifetilactone B
|
6S-Hydroxy-2Z-icosen-5S-olide
|
FA 20:2;O
|
C20H36O3
|
324.266445
|
LMFA07040198
|
Passifetilactone A
|
2Z,13Z-icosadien-5S-olide
|
FA 20:3
|
C20H34O2
|
306.255880
|
LMFA07070135
|
cis-3,4-methylene-heptanoyl-R-carnitine
|
cis-3,4-methylene-heptanoyl-R-carnitine
|
CAR 8:1
|
C15H27NO4
|
285.194009
|
LMFA07011198
|
HSN-S1
|
2R,3R,4R,5R,6-pentahydroxyhexyl octadeca-6Z,9Z,12Z,15Z-tetraenoate
|
WE 24:4;O5
|
C24H40O7
|
440.277405
|
LMFA07100017
|
Lahorenoic acid B
|
Methyl 6-(2-((E)-3-oxobut-1-enyl)phenyl)hexanoate
|
SFE 17:6;O
|
C17H22O3
|
274.156895
|